Tissue Regenix Group Plc

Tissue Regenix (TRX)

Buy
Sell
Company name:Tissue Regenix Group Plc
EPIC:TRXTrading Currency:GBX
Market Sector:AMQ1ISIN:GB00B5SGVL29
Market Segment:ASQ1Share Type:DE
WWW Address:http://www.tissueregenix.com/Description:ORD 0.1P
Industry Sector:PHARMACEUTICALS & BIOTECHNOLOGY
 Price Price Change [%] Bid Offer Open High Low Volume
 0.38 images.advfn.com/imagesnew/2/gb/dot 0.0 [0.00] 0.36 0.39 0.38 0.38 0.38 13,838,906
 Market Cap. [m] Shares In Issue [m] Beta EPS DPS PE Ratio Yield 52-Wks-Range
 26.37 7,032.99 -0.00 -0.60 - - - 3.00 - 0.28

Tissue Regenix Key Figures

(at previous day's close)
Market Cap.26.37m
Shares In Issue7,032.99m
Prev. Close0.38
PE Ratio- 
Dividend Yield-%
EPS - basic-0.60p
Dividend PS-p
Dividend Cover- 
Cash Flow PS-0.10p
Return On Equity (ROE)-30.53%
Operating Margin-58.77%
PEG Factor- 
EPS Growth Rate14.29%
Dividends PS Growth Rate-%
Net Debt3.52m
Gross Gearing19.35%
Quick Assets5.95m
Net Working Capital7.02m
Intangibles / Fixed Assets88.42%
Turnover PS0.19p
Pre-Tax Profit PS-0.11p
Retained Profit PS-0.11p
Cash PS0.03p
Net Cash PS-0.01p
Net Tangible Asset Value PS *0.10p
Net Asset Value PS0.35p
Spread0.03 (7.69%) 

Tissue Regenix Balance Sheet

LSE:TRX:Liabilities+EQLSE:TRX:Assets

Share Price Performance

Sample Period HighLow
1 week0.380.36
4 weeks0.380.33
12 weeks0.380.30
1 year3.000.28

Share Price Chart (5 years)

Tissue Regenix Historic Returns

Period OpenChange%Open Avg.Avg. Daily Vol [m]Total Vol [m]VWAP
1 week0.38-0.01-1.320.3615.970.37
4 weeks0.340.0411.940.3324.740.36
12 weeks0.330.0515.380.3033.440.34
26 weeks0.83-0.45-54.550.2844.520.40
1 year2.75-2.38-86.360.2842.100.73
3 years9.25-8.88-95.950.2814.750.80
5 years16.75-16.38-97.760.288.901.03

Tissue Regenix Key Management Ratios

Tissue Regenix Investment Ratios

(Market value analysis) at previous day's close
PQ Ratio- 
PE Ratio- 
Tobin's Q Ratio 0.77 
Tobin's Q Ratio (excl. intangibles)1.75 
Dividend Yield-%
Market-to-Book Ratio1.05 
Price-to-Pre-Tax Profit PS-3.44 
Price-to-Retained Profit PS-3.43 
Price-to-Cash Flow PS-3.95 
Price-to-Sales PS2.02 
Price-to-Net Tangible Asset Value PS4.00 
Price-to-Cash PS11.08 
Net Working Capital PS0.10 
Price Pct to Working Capital PS3.75%
Earnings Yield-%
Average PE- 
Years in average- 
PE to PE average-%

Tissue Regenix Financial Ratios

(Leverage Ratios)
Debt Ratio10.17%
Debt-to-Equity Ratio0.11 
Debt-to-Equity Ratio (excl. Intgbl)0.42 
Debt-to-Equity Market Value0.11 
Net Gearing11.54%
Net Gearing (excl. Intangibles)28.17%
Gross Gearing19.35%
Gross Gearing (excl. Intangibles)47.22%
Gearing Under 1 Year10.21%
Gearing Under 1 Year (excl. Intgbl)24.93%
Assets/Equity1.24 
Cash/Equity9.68 
(Liquidity Ratios)
Net Working Capital to Total Assets23.03%
Current Ratio3.25 
Quick Ratio (Acid Test)1.91 
Liquidity Ratio0.76 
Cash & Equiv/Current Assets23.47%
(Solvency Ratios)
Enterprise Value26.16m
CFO/Sales-0.51 
CFO/Attributable Profit- 
CFO/Assets-0.22 
CFO/Debt-1.13 
Total Debt/Equity Market Value0.22 
Total Debt/Sales0.45 
Total Debt/Pre-Tax Profit-0.77 
Total Debt5.90m
Total Debt/Net Current Assets0.84%
(Dodds - Graham Ratios)
3 yr Compound Earnings Growth-15.66%
5 yr Compound Earnings Growth-13.93%
10 yr Compound Earnings Growth-8.63%
Earn drops > 5% in 10yrs4 
Beta (60-Mnth)Beta (36-Mnth)
-0.00110.0070

Tissue Regenix Operating Ratios

(Profitability Ratios)
Return On Capital Employed (ROCE)-27.98%
Return On Assets (ROA)-22.59%
Net Profit Margin-59.06%
Assets Turnover0.38 
Return On Equity (ROE)-30.53%
Return On Investment (ROI)-25.34%
Dividend Payout Ratio-%
Plowback Ratio100.00%
Growth from Plowback Ratio-%
Net Income Of Revenues-59.06%
(Asset Utilisation Multiples)
Shareholders Equity Turnover0.45 
Fixed Assets Turnover0.60 
Current Assets Turnover1.04 
Net Working Capital Turnover 
Inventory Turnover4.00 
(Other Operating Ratios)
Total Assets-to-Sales2.61 
Debtors-to-Sales31.94%
Debt Collection Period116.57Days

Tissue Regenix Dividends

Sorry No Data Available

Tissue Regenix Fundamentals

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
turnover1.44100.00%5.23100.00%11.62100.00%13.03100.00%m
pre tax profit-10.95-758.56%-10.77-205.79%-8.88-76.42%-7.66-58.77%m
attributable profit-9.79-678.17%-9.22-176.21%-8.19-70.45%-7.70-59.06%m
retained profit-9.79-678.17%-9.22-176.21%-8.19-70.45%-7.70-59.06%m
eps - basic (p)-1.29 -1.00 -0.70 -0.60 
eps - diluted (p)-1.29 -1.00 -0.70 -0.60 
dividends per share- - - - 

Tissue Regenix Balance Sheet

 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
LSE:TRX:Liabilities+EQLSE:TRX:AssetsLSE:TRX:Liabilities+EQLSE:TRX:AssetsLSE:TRX:Liabilities+EQLSE:TRX:AssetsLSE:TRX:Liabilities+EQLSE:TRX:Assets
 31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
ASSETS
fixed assets fixed assets1.097.99%2.996.54%2.837.51%2.367.73%m
intangibles intangibles0.554.04%19.3142.19%19.9452.94%18.0059.02%m
fixed investments fixed investments--%--%--%--%m
current assets - other current assets - other--%--%--%--%m
stocks stocks0.664.86%2.876.28%2.336.19%4.1913.72%m
debtors debtors3.1323.01%4.179.11%4.7512.61%3.5711.72%m
cash & securities cash & securities8.1760.09%16.4235.89%7.8220.75%2.387.80%m
TOTAL13.60100%45.76100%37.66100%30.50100%m
LIABILITIES
creditors - short creditors - short2.0715.18%4.7810.45%4.3011.42%3.1210.21%m
creditors - long creditors - long--%0.641.39%0.792.10%2.799.13%m
creditors - other creditors - other--%0.821.80%--%--%m
subordinated loans subordinated loans--%--%--%--%m
insurance funds insurance funds--%--%--%--%m
TOTAL2.0715.18%6.2413.64%5.0913.52%5.9019.35%m
EQUITY
ord cap, reserves ord cap, reserves11.7586.35%39.9387.26%33.0587.76%25.2182.67%m
prefs, minorities prefs, minorities-0.21-1.54%-0.41-0.89%-0.48-1.28%-0.62-2.02%m
TOTAL11.5484.82%39.5286.36%32.5786.48%24.6080.65%m
OTHER
NAV Basic- - - - 
NAV Diluted- - - - 

Tissue Regenix Cash Flow Statement

31 Dec 2016 (GBP)31 Dec 2017 (GBP)31 Dec 2018 (GBP)31 Dec 2019 (GBP)
Operating CF-10.81-9.79-6.84-6.68m
Pre-Financing CF-11.73-29.91-8.74-7.32m
Retained CF-11.738.08-8.73-5.41m

Tissue Regenix Brokers

NameActivityTypeMnemonicCode
Evolution Securities LimitedMarket Maker(MME)Broker/DealerEVOEVBGGB21MMT
Jefferies International LtdMarket Maker(MME)Broker/DealerJEFFJEFFGB2X
Morgan Stanley Securities LtdMarket Maker(MME)Broker/DealerMOSTMSSEGB21
Numis Securities LimitedMarket Maker(MME)Broker/DealerNUMSRAZHGB2LBIC
Shore Capital Stockbrokers LtdMarket Maker(MME)Broker/DealerSCAPSHOCGB21
Merrill Lynch InternationalMarket Maker(MME)Broker/DealerMLSBSNCSGB2LBIC
UBS AGMarket Maker(MME)Broker/DealerUBS.UBSWGB2LEQU
Winterflood Securities LtdMarket Maker(MME)Broker/DealerWINSWNTSGB2LBIC
ADVFN Advertorial
Your Recent History
LSE
TRX
Tissue Reg..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20201021 19:18:59